
Pamela Rodriguez
Examiner (ID: 16616, Phone: (571)272-7122 , Office: P/3657 )
| Most Active Art Unit | 3657 |
| Art Unit(s) | 3613, 3683, 3642, 3657, 3103, 3616 |
| Total Applications | 1957 |
| Issued Applications | 1629 |
| Pending Applications | 123 |
| Abandoned Applications | 230 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6682783
[patent_doc_number] => 20030118647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Extended release tablet of metformin'
[patent_app_type] => new
[patent_app_number] => 10/005387
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2465
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118647.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005387 | Extended release tablet of metformin | Dec 3, 2001 | Abandoned |
Array
(
[id] => 1263446
[patent_doc_number] => 06660296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-09
[patent_title] => 'Sustained-release microgranules containing diltiazem as active principle'
[patent_app_type] => B2
[patent_app_number] => 09/998911
[patent_app_country] => US
[patent_app_date] => 2001-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12316
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/660/06660296.pdf
[firstpage_image] =>[orig_patent_app_number] => 09998911
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998911 | Sustained-release microgranules containing diltiazem as active principle | Dec 2, 2001 | Issued |
Array
(
[id] => 1056111
[patent_doc_number] => 06855334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-15
[patent_title] => 'Controlled delivery of active agents'
[patent_app_type] => utility
[patent_app_number] => 10/001116
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 15130
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/855/06855334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001116 | Controlled delivery of active agents | Nov 26, 2001 | Issued |
Array
(
[id] => 5786445
[patent_doc_number] => 20020160040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Cubic liquid crystalline compositions and methods for their preparation'
[patent_app_type] => new
[patent_app_number] => 09/990552
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8301
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160040.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990552
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990552 | Cubic liquid crystalline compositions and methods for their preparation | Nov 20, 2001 | Issued |
Array
(
[id] => 6612420
[patent_doc_number] => 20020064562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => new
[patent_app_number] => 10/016041
[patent_app_country] => US
[patent_app_date] => 2001-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4542
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20020064562.pdf
[firstpage_image] =>[orig_patent_app_number] => 10016041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/016041 | Pharmaceutical formulations comprised of amoxicillin in combination with clavulanic acid | Nov 18, 2001 | Issued |
Array
(
[id] => 5901213
[patent_doc_number] => 20020140137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Inorganic shaped bodies and methods for their production and use'
[patent_app_type] => new
[patent_app_number] => 09/999506
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 26446
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20020140137.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999506
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999506 | Inorganic shaped bodies and methods for their production and use | Nov 14, 2001 | Issued |
Array
(
[id] => 1342960
[patent_doc_number] => 06582727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-24
[patent_title] => 'Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same'
[patent_app_type] => B2
[patent_app_number] => 10/008694
[patent_app_country] => US
[patent_app_date] => 2001-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10076
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/582/06582727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10008694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/008694 | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same | Nov 7, 2001 | Issued |
Array
(
[id] => 1112449
[patent_doc_number] => 06803032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-12
[patent_title] => 'Astringent shave preparations'
[patent_app_type] => B2
[patent_app_number] => 10/008663
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1068
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/803/06803032.pdf
[firstpage_image] =>[orig_patent_app_number] => 10008663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/008663 | Astringent shave preparations | Nov 6, 2001 | Issued |
Array
(
[id] => 6429045
[patent_doc_number] => 20020127202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Compounds and compositions for delivering active agents'
[patent_app_type] => new
[patent_app_number] => 10/005511
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11034
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127202.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005511
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005511 | Compounds and compositions for delivering active agents | Nov 6, 2001 | Issued |
Array
(
[id] => 1199410
[patent_doc_number] => 06723339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-20
[patent_title] => 'Oil-free pharmaceutical compositions containing cyclosporin A'
[patent_app_type] => B2
[patent_app_number] => 09/992584
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3770
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723339.pdf
[firstpage_image] =>[orig_patent_app_number] => 09992584
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/992584 | Oil-free pharmaceutical compositions containing cyclosporin A | Nov 5, 2001 | Issued |
Array
(
[id] => 6450746
[patent_doc_number] => 20020177579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Extended release formulation of water-soluble drugs'
[patent_app_type] => new
[patent_app_number] => 10/012227
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8235
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177579.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012227
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012227 | Extended release formulation of water-soluble drugs | Nov 4, 2001 | Abandoned |
Array
(
[id] => 1188552
[patent_doc_number] => 06733783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => B2
[patent_app_number] => 10/016651
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12667
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/733/06733783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10016651
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/016651 | Controlled release hydrocodone formulations | Oct 29, 2001 | Issued |
Array
(
[id] => 6208252
[patent_doc_number] => 20020071809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Effervescent drug delivery system for oral administration'
[patent_app_type] => new
[patent_app_number] => 10/021486
[patent_app_country] => US
[patent_app_date] => 2001-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4007
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20020071809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021486 | Effervescent drug delivery system for oral administration | Oct 28, 2001 | Issued |
Array
(
[id] => 6128513
[patent_doc_number] => 20020076439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Effervescent drug delivery system for oral administration'
[patent_app_type] => new
[patent_app_number] => 10/021109
[patent_app_country] => US
[patent_app_date] => 2001-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4011
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021109 | Effervescent drug delivery system for oral administration | Oct 28, 2001 | Issued |
Array
(
[id] => 1329898
[patent_doc_number] => 06596307
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Process for preparing pharmaceutical bulk material having uniform dissolution'
[patent_app_type] => B1
[patent_app_number] => 10/049540
[patent_app_country] => US
[patent_app_date] => 2001-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4885
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596307.pdf
[firstpage_image] =>[orig_patent_app_number] => 10049540
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/049540 | Process for preparing pharmaceutical bulk material having uniform dissolution | Oct 25, 2001 | Issued |
Array
(
[id] => 6375194
[patent_doc_number] => 20020119194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Pharmaceutical forms for the oral administration of mesna'
[patent_app_type] => new
[patent_app_number] => 09/982098
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 709
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119194.pdf
[firstpage_image] =>[orig_patent_app_number] => 09982098
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/982098 | Pharmaceutical forms for the oral administration of mesna | Oct 18, 2001 | Abandoned |
Array
(
[id] => 1238538
[patent_doc_number] => 06685927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-03
[patent_title] => 'Topical application of chromophores for hair removal'
[patent_app_type] => B2
[patent_app_number] => 09/965354
[patent_app_country] => US
[patent_app_date] => 2001-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3986
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/685/06685927.pdf
[firstpage_image] =>[orig_patent_app_number] => 09965354
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/965354 | Topical application of chromophores for hair removal | Sep 26, 2001 | Issued |
Array
(
[id] => 1493521
[patent_doc_number] => 06403120
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Extended release formulation of venlafaxine hydrochloride'
[patent_app_type] => B1
[patent_app_number] => 09/950965
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4944
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403120.pdf
[firstpage_image] =>[orig_patent_app_number] => 09950965
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/950965 | Extended release formulation of venlafaxine hydrochloride | Sep 11, 2001 | Issued |
Array
(
[id] => 6471218
[patent_doc_number] => 20020022056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Oxacarbazepine film-coated tablets'
[patent_app_type] => new
[patent_app_number] => 09/947574
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3786
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022056.pdf
[firstpage_image] =>[orig_patent_app_number] => 09947574
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/947574 | Oxacarbazepine film-coated tablets | Sep 5, 2001 | Abandoned |
Array
(
[id] => 1298047
[patent_doc_number] => 06623759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-23
[patent_title] => 'Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof'
[patent_app_type] => B2
[patent_app_number] => 09/947166
[patent_app_country] => US
[patent_app_date] => 2001-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7520
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/623/06623759.pdf
[firstpage_image] =>[orig_patent_app_number] => 09947166
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/947166 | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof | Sep 4, 2001 | Issued |